crispr-cas9
The Crispr-Cas9 patent tussle continues: The case of UC Berkeley at the EPO
By Joanna Applequist | Posted on November 15, 2019
In Europe, we don’t do things the way the Americans do… Oral proceedings in the opposition against UC Berkeley’s (UC’s) main European patent EP2800811 are scheduled for all of three (!) days in February of 2020 at the European Patent Office (EPO). The opposition division’s (OD’s) preliminary and non-binding opinion, provided on the 30th of...
Broad Institute maintains patents to Gene Scissors in the US
By Joanna Applequist | Posted on February 17, 2017
The CRISPR-Cas9 technology, the so called “gene scissors” which allow for targeted genome-editing, is subject to a patent dispute between two research teams lead by Jennifer Doudna at UC Berkeley and Emanuelle Charpentier then at the University of Vienna on one hand, and Feng Zhang’s lab at the Broad Institute and MIT on the other....
Tags: cas9, crispr, crispr-cas9
Recent contributors
Partner, European Patent Attorney
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
